medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2009, Number 2

Next >>

Rev Mex Oftalmol 2009; 83 (2)

Síndrome de pseudoexfoliación. Revisión bibliográfica

Urrutia-Breton IP

Language: Spanish
References: 62
Page: 57-66
PDF size: 209.71 Kb.


ABSTRACT

Pseudo exfoliation syndrome is an age-related generalized fibrotic matrix process, which may not only cause severe chronic open angle glaucoma and cataract, but also a spectrum of other serious spontaneous and surgical intraocular complications. Recent progress and advances have led to improvements in clinical managements by understanding the effects of the pseudo exfoliation process on ocular tissues, by refining diagnostic criteria, by applying new treatment regimes, and by developing preventive strategies to reduce surgical complications; and increasing evidence for systemic associations of pseudo exfoliation with cardiovascular and cerebrovascular morbidity. The current pathogenetic concept describes pseudo exfoliation syndrome as an elastic microfibrillopathy involving transforming growth factor-B1, oxidative stress, and impaired cellular protection mechanisms as key pathogenetic factors.


REFERENCES

  1. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophtalmol 2001; 45:265-315.

  2. Lindberg JG. Clinical investigations on depigmentation of the pupilary border and translucency of the iris. Acta Ophthalmol 1989; 67(supl 190):1-96.

  3. Rich R. Exfoliation syndrome. Beyond glaucoma (Editorial). Arch Ophthalmol 2008; 126(6).

  4. Schlötzer-Schrehardt U, Naumann GOH. Perspective. Ocular and systemic Pseudoexfoliation. Am J Ophthalmol 2006; 141(5): 921-937.

  5. Ringvold A. Epidemiology of the pseudoexfoliation syndrome. Acta Ophthalmol Scand 1999; 77:371-375.

  6. Forsius H, Forsman E, Fellman J, Eriksson AW. Exfoliation Syndrome: frequency, gender distribution and association with climatically induced alterations of the cornea and conjunctiva. Acta Ophthalmol Scan 2002; 80:478-484.

  7. Damji KF, Bains HS, Steffansson E y cols. Is pseudoexfoliation syndrome inherited? A review of genetic and non genetic factors a new observation. Ophthalmic Genetics 1998; 19:175-185.

  8. Kozobolis VP, Detorakis ET, Sourvinos G, Pallikaris IG, Spandidos DA. Loss of heterozygosity in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 1999; 40:1255-1260.

  9. Ritch R. Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc 1994; 92:845-944.

  10. Von der Lippe I, Küchle M, Nauman GOH. Pseudoexfoliation syndrome as a risk factor for acute ciliary block angle closure glaucoma. Acta Ophtahmol 1993; 71:277-279.

  11. Asano N, Schlötzer-Schrehardt U, Nauman GOH. A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology 1995; 102:1279-1290.

  12. Helbig H, Schlötzer-Schrehardt U, Noske W y cols. Anterior chamber hypoxia and iris vasculopaty in pseudoexfoliation syndrome. German J Ophthalmol 1994; 3:148-153.

  13. Küchle M, Nguyen N, Hannapel E. The blood-aqueous barrier in eyes with pseudoexfoliation syndrome. Ophthalmic Res 1995; 27(supl 1):136-142.

  14. Nguyen NX, Küchle M, Martus P, Nauman GOH. Quantification of blood-aqueous barrier breakdown after trabeculectomy: pseudoexfoliation versus primary open-angle glaucoma. J Glaucoma 1998; 18-23.

  15. Schlötzer-Schrehardt U, Nauman GOH. Trabecular Meshwork in pseudoexfoliation syndrome with and without open angle glaucoma: a morphometric, ultraestructural study. Invest Ophthalmol Vis Sci. 1995; 36:1750-1764.

  16. Gottanka J, Flügel-Koch C, Martus P. Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 1997; 38:2435-2446.

  17. Cobb CJ, Blanco G, Spaeth L. Exfoliation syndrome angle characteristics: a lack of correlation with amount of disc damage. Br J Ophthalmol 2004; 88:1002-1003.

  18. Yüksel N, Karabas VL, Arslan A, Demirci A, Caglar Y. Ocular hemodynamics in pseudoexfoliation syndrome glaucoma. Ophthalmology 2001; 108:1043-1049.

  19. Harju M, Vesti E. Blood flow of the optic nerve and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2001; 239:271-277.

  20. Ocakoglu O, Koyluoglu N, Kayiran A, Tamcelik N, Ozkan S. Microvascular blood flow of the optic nerve head and peripapillary retinal in unilateral exfoliation syndrome. Acta Ophthalmol Scand 2004; 82:49-53.

  21. Netland PA, Ye H, Streeten BW, Hernandez MR. Elastosis of the lamina cribosa in pseudoexfoliation syndrome with glaucoma. Ophthalmology 1995; 102:878-886.

  22. Puska P, Vesti E, Tomita G, Ishida K, Raitta C. Optics disc changes in normotensive persons with unilateral exfoliation syndrome: a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol 1999; 237:457-462.

  23. Tarkkanen A, Kivelä T. Cumulative incidence of converting from clinically unilateral to bilateral exfoliation syndrome. J Glaucoma 2004; 13:181-184.

  24. Nauman GOH, Schlötzer-Schrehardt U. Keratopathy in pseudoexfoliation syndrome as a cause of corneal endothelial decompensation: a clinicopathologic study. Ophthalmology 2000; 107:111-1124.

  25. Schlötzer- Shredardt U, Naumman GOH. A histopatologic study of zonular instability in pseudoexfoliation syndrome. Am J Ophthalmol 1994; 118:730-743.

  26. Inazumi K, Takahashi D, Taniguchi T, Yamamoto T. Ultrasound biomicroscopy clasification of zonules in exfoliation syndrome. Jpn J Ophthalmol 2002; 46:502-509.

  27. Sbeity Z, Dorairaj SK, Reddy S y cols. Ultrasound biomicroscopy of zonular anatomy in clinically unilateral exfoliation syndrome. Acta Ophthalmol 2008; (86)5:565-8.

  28. Comway RM, Schlötzer-Schrehardt U, Küchle M, Nauman GOH. Pseudoexfoliation syndrome: pathologic manifestations of relevance to intraocular surgery. Clin Exp Ophthalmol 2004; 32:199-210.

  29. Küchle M, Viestenz A, Martus P, Händel A, Jünemann A, Nauman GOH. Anterior chamber depth and complications during cataract surgery in eyes with pseudoexfoliation syndrome. Am J Ophtalmol 2000; 129:281-285.

  30. Nihalani BR, Jani UD Vasavada AR, Auffahrt GU. Cataract surgery in relative anterior microphthalmos. Ophthalmology 205; 112:1360-1367.

  31. Moreno-Montanes J, Rodriguez-Conde R. Capsular tension ring in eyes with pseudoexfoliation. J Cataract Refract Surg 2002; 28:2241-2242.

  32. Katsimpris JM, Petropoulus IK, Apostolakis K, Feretis D. Comparing phacoemulsification and extracapsular cataract extraction in eyes with pseudoexfoliation syndrome, small pupil, and phacodonesis. Klin Monatsbl Augenhilkd 2004; 221:328-323.

  33. Nagashima RJ. Decreased incidence of capsule complications and vitreous loss during phacoemulsification in eyes with pseudoexfoliation syndrome. J Cataract Refract Surg 2004; 30:127-131.

  34. Hyams M, Mathalone N,Herkovitz M, Hod Y, Israeli D, Geyer O. Intraoperative complications of phacoemulsification in eyes with and without pseudoexfoliation. J Cataract Refract Surg 2005; 31:1002-1005.

  35. Ritch R. Exfoliation syndrome: the most common identificable cause of open angle glaucoma. J Glaucoma 1996; 3:176-178.

  36. Bialasiewicz AA, Wali U, Shenoy R, Al-Saeidi R. Patientswith secondary open-angle glaucoma in pseudoexfoliation syndrome (PEX) among a population with high prevalence of PEX: clinical findings and morphological and surgical characteristics: Ophthalmologue 2005; 102:1064-1068.

  37. Lanzl IM, Merte RL, Graham AD. Does head positioning influence anterior chamber depth in pseudoexfoliation? J Glaucoma 2000; 9:214-218.

  38. Teus MA, Castejon MA, Calvo MA. Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma. Ophthalmology 1998; 105:2225-2229.

  39. Gumus K, Bozkurt B, Sonmez B, Irkec M, Orhan M, Saracbasi O. Diurnal variation of intraocular pressure and its correlation with retinal nerve fiber analysis in Turkish patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2005;2:1-7.

  40. Konstas AGP, Mylopoulus N, Karabatsas CH y cols. Diurnal intraocular presure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye 2004; 18:893-899.

  41. Puska PM. Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma –a prospective 10 year follow-up study. J Glaucoma 2002; 11:517-524.

  42. Johnson TV, Fan S, Camras CB, Toris CB. Aqueous humor dynamics in exfoliation syndrome. Arch Ophthalmol 2008;126(7):914-20.

  43. Konstas AGP, Koliakos GG, Liakos P y cols. Latanoprost therapy reduces the levels of TGB beta 1 and gelatinases in the aqueous humor of patients with exfoliative glaucoma. Exp Eye Res 2005; 82:319-322.

  44. Krupin T, Feitl ME, Bishop KI. Postoperative intraocular pressure rise in open-angle glaucoma patients after cataract or combined cataract filtration surgery. Ophthalmology 1989; 96:579-584.

  45. Levcovitch-Verbin H. Habot-Winer Z, Burla N y cols. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome. Ophthalmology; 2000:104-108.

  46. Cahill M, Early A, Stack S, Blayney AW, Eustace P. Pseudoexfoliation and neurosensorial hearing loss. Eye 2002; 16:261-266.

  47. Sekeroglu MA, Bozkurt B, Ireck M y cols. Systemic Associations and prevalence of exfoliation syndrome on patients scheduled for cataract surgery. Eur J Ophthalmol 2008; 18(4):551-5.

  48. Tarkkanen A, Reunanen A, Kivelä T. Frecuency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophtahlmol 2008; 86(6):598-602.

  49. Ritland JS Egge K, Lydersen S, Juu R, Semb SO. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 2004; 82:401-404.

  50. Ringvold A. A preliminary report on the aminoacid composition of the pseudoexfoliation material (PEX material). Exp Eye Res 1973; 15:37-42.

  51. Gartaganis SP, Georgakopoulos CD, Exarchou AM y cols. Increased aqueous humor basic fibroblast growth factor and hyaluronan levels in relation to the exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol Scand 2001; 79:572-575.

  52. Hu D-N, Ritch R. Hepatocyte growth factor is increased in the humor of glaucomatous eyes. J Glaucoma 2001; 10:152-157.

  53. Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Nauman GOH. Role of transforming growth factor-B-1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 2000; 1(73):765-780.

  54. Ho SL, Dogar GF, Wang J y cols. Elevated humor aqueous humor tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol 2005: 89:169-173.

  55. Gartaganis SP, Georgakopoulus CD, Mela EK y cols. Matrix metalloproteinases and their inhibitors in exfoliation syndrome. Ophthalmic Res 2002; 34:165-171.

  56. Schlötzer-Schrehardt U, Lommatzsch J, Küchle M y cols. Matrix metalloproteinases and their inhibitors in aqueous humour of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003; 44:1117-1125.

  57. Koliakos GG, Konstas AGP, Schlötzer-Schrehardt U y cols. 8- Isoprostaglandin F2A and ascorbic acid concentration in the aqueous humor of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87:353-356.

  58. Koliakos, Konstas AGP, Schlötzer-Schrehardt U y cols. Endothelin-1 concentration is increased in the aqueous humor of patients with exfoliation syndrome. Br J Ophthalmol 2004; 88:523-527.

  59. Cursiefen, Händel A, Schönherr U, Nauman GOH. Pseudoexfoliation syndrome in patients with branch and central vein thrombosis. Klin Monatsbl Augenheikd 1997; 211:17-21.

  60. Gillies WE, Brooks AMV. Central retina vein occlusion in pseudoexfoliation of the lens capsule. Clin Exp Ophthalmol 2002; 30:176-178.

  61. Streeten BW, Gibson SA, Dark AJ. Pseudoexfoliative material contains an elastic microfibrilar-associated glycoprotein. Trans Am Ophthalmol Soc 1986; 84:304-320.

  62. Zalewska R, Pepinski W, Smolenska-Janica D y cols. Loss of heterozygosity in patients with pseudoexfoliation syndrome. Mol Vis 2003; 9:257-261.




2020     |     www.medigraphic.com